Cardlytics (CDLX) Tops Q4 EPS by 51c

Cardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.29), $0.51 better than the analyst estimate of ($0.80). Revenue for the quarter came in at $82.5 million versus the consensus estimate of $83.54 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Hitachi Ltd. (HIT) Misses Q2 EPS by 7c
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c